Open retropubic prostatectomy in patients with localized prostate cancer
Închide
Articolul precedent
Articolul urmator
74 0
SM ISO690:2012
GALESCU, Andrei, ȘADUROV, Mihail, IVANOV (LITOVCENCO), Mihaela, BANOV, Pavel, BRADU, Andrei, SCUTARI, A., DUMBRĂVEANU, Ion, CEBAN, Emil. Open retropubic prostatectomy in patients with localized prostate cancer. In: New horizons in urology: The 8th congress on urology, dialysis and kidney transplant from Republic of Moldova with international participation, 7-9 iunie 2023, Chişinău. Chişinău: Taicom (Ridgeone Group), 2023, p. 357. ISSN 2558-815X.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
New horizons in urology 2023
Conferința "New horizons in urology"
Chişinău, Moldova, 7-9 iunie 2023

Open retropubic prostatectomy in patients with localized prostate cancer


Pag. 357-357

Galescu Andrei12, Șadurov Mihail12, Ivanov (Litovcenco) Mihaela12, Banov Pavel12, Bradu Andrei21, Scutari A.1, Dumbrăveanu Ion1, Ceban Emil1
 
1 ”Nicolae Testemițanu” State University of Medicine and Pharmacy,
2 Timofei Moșneaga Republican Clinical Hospital
 
 
Disponibil în IBN: 27 martie 2024


Rezumat

Introduction. Patients with localized prostate cancer are candidates for surgery, radiation therapy, or active surveillance. Open retropubic prostatectomy (ORP) is the most common surgical treatment in the Republic of Moldova. Aim of study. Were to evaluate the effectiveness of ORP and to study early and long-term postoperative outcomes in patients with localized prostate cancer. Methods. In the period from June 2021 to February 2023, ORP was performed in 20 patients with localized prostate cancer at the Urology Department of the IMSP SCR «Timofei Mosneaga». The mean age of the patients was 67.3 years. The mean preoperative PSA was 12 ng/ml. In 8 patients (40%) was determined a low risk of biochemical recurrence, in 8 patients (40%) was established intermediate risk and in 4 patients (20%) high risk of biochemical recurrence. According to the TNM classification for prostate cancer (2017), the distribution was as follows: T1a – 2 patients (10%), T1c – 14 patients (70%), T2a-T2c – 4 patients (20%). Extended pelvic lymphadenectomy preceded prostatectomy in 9 patients (45%). Results. Among the intraoperative complications, there was bleeding from the veins of the Santorini plexus in 3 cases. In the postoperative period, one patient had prolonged lymphorrhea. The median number of days a patient spent in hospital after surgery was 8 days (3-25). Removal of the urethral catheter was performed on the 3-4th week. Urinary continence was restored in patients within six months after surgery. Conclusion. ORP is an effective surgical method for treatment of clinically localized prostate cancer with low level of postoperative complications.